Indeed, the tumor promoting effects could be abrogated by KIF2C-silencing and restored by addition of exogenous PAF, indicating a possible regulatory role of KIF2C in MEK/ERK signaling transduction [109]. The gene discussed is KIF2C; the disease is neoplasm.